Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.29
+0.03 (0.48%)
Mar 12, 2026, 10:24 AM EDT - Market open
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $100.58 million as of March 12, 2026. Its market cap has increased by 63.56% in one year.
Market Cap
100.58M
Enterprise Value
71.58M
1-Year Change
63.56%
Ranking
Category
Stock Price
$6.29
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.56M to $100.58M, a decrease of -76.96%. That is a compound annual growth rate of -17.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 100.10M | -24.67% |
| Dec 31, 2025 | 132.88M | 109.60% |
| Dec 31, 2024 | 63.40M | -79.41% |
| Dec 29, 2023 | 307.91M | 172.47% |
| Dec 30, 2022 | 113.01M | -55.17% |
| Dec 31, 2021 | 252.07M | -15.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 103.93M |
| Dogwood Therapeutics | 103.22M |
| Turn Therapeutics | 103.06M |
| Seer, Inc. | 99.86M |
| Anixa Biosciences | 99.47M |
| Cognition Therapeutics | 98.87M |
| Pyxis Oncology | 96.51M |
| Vivani Medical | 93.43M |